Literature DB >> 12615687

Prognostic value of abnormal vasoreactivity of epicardial coronary arteries to sympathetic stimulation in patients with normal coronary angiograms.

Thomas H Schindler1, Burkhard Hornig, Peter T Buser, Manfred Olschewski, Nobuhisa Magosaki, Matthias Pfisterer, Egbert U Nitzsche, Ulrich Solzbach, Hanjörg Just.   

Abstract

OBJECTIVE: We aimed to evaluate prospectively whether patients with normal coronary angiogram but abnormal epicardial vasoreactivity to cold pressor test (CPT) are at increased risk for cardiovascular events. METHODS AND
RESULTS: Vasoreactivity in response to CPT and dilation of epicardial arteries to intracoronary application of nitroglycerin were assessed quantitatively (percent change of luminal area, DeltaLA%) in 130 patients with normal coronary angiograms. Cardiovascular events (cardiovascular death, acute coronary syndrome, myocardial infarction, percutaneous transluminal coronary angioplasty, coronary bypass grafting, ischemic stroke, or peripheral revascularization) were assessed as clinical outcome parameters over a mean follow-up period of 45+/-9 months. Based on their vascular responses to CPT, patients were assigned into the following 3 groups: group 1, patients with normal vasodilator response (DeltaLA >0%; n=37); group 2, patients with moderate vasoconstrictor response (DeltaLA between 0% and -15%; n=42); and group 3, patients with severe vasoconstrictor response (DeltaLA < or =-15%; n=51). Although patients from groups 2 and 3 had significantly increased vasoconstrictor response to CPT (group 2, DeltaLA -6+/-3% and group 3, DeltaLA -24+/-6% versus group 1, DeltaLA 11+/-9%; P< or =0.0001), they showed normal endothelial-independent epicardial vasodilation to intracoronary application of nitroglycerin similar to patients from group 1 (DeltaLA 39+/-16% and 34+/-14% versus 41+/-14%; P=NS, respectively). During follow-up, none of the patients from group 1 developed cardiac events. However, 7 cardiovascular events occurred in group 2 and 30 occurred in group 3 in 4 and 22 patients, respectively (P< or =0.0001, univariate by log-rank test). After adjustment for known risk factors for coronary artery disease, impaired epicardial coronary vasoreactivity to CPT remained significantly associated with the risk of developing cardiovascular events (P=0.040, multivariate by Cox regression model).
CONCLUSIONS: In patients with normal coronary angiogram, abnormal vasoreactivity of epicardial coronary arteries in response to sympathetic stimulation is associated with the risk of developing cardiovascular events.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12615687     DOI: 10.1161/01.ATV.0000057571.03012.F4

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  38 in total

1.  Assessment of coronary flow reserve and microcirculation: a clinical perspective.

Authors:  Roxana Campisi; Marcelo F Di Carli
Journal:  J Nucl Cardiol       Date:  2004 Jan-Feb       Impact factor: 5.952

2.  Update on nitric oxide-dependent vasodilation in human subjects.

Authors:  Craig J McMackin; Joseph A Vita
Journal:  Methods Enzymol       Date:  2005       Impact factor: 1.600

Review 3.  Advances in positron emission tomography.

Authors:  Marcelo F Di Carli
Journal:  J Nucl Cardiol       Date:  2004 Nov-Dec       Impact factor: 5.952

Review 4.  Endothelial function and clinical outcome.

Authors:  J A Vita
Journal:  Heart       Date:  2005-10       Impact factor: 5.994

5.  PET-measured heterogeneity in longitudinal myocardial blood flow in response to sympathetic and pharmacologic stress as a non-invasive probe of epicardial vasomotor dysfunction.

Authors:  Thomas H Schindler; Alvaro D Facta; John O Prior; Roxana Campisi; Masayuki Inubushi; Michael C Kreissl; Xiao-Li Zhang; James Sayre; Magnus Dahlbom; Heinrich R Schelbert
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-04-26       Impact factor: 9.236

Review 6.  Role of PET in the evaluation and understanding of coronary physiology.

Authors:  Thomas H Schindler; Xiao-Li Zhang; Gabriella Vincenti; Leila Mhiri; René Lerch; Heinrich R Schelbert
Journal:  J Nucl Cardiol       Date:  2007-07       Impact factor: 5.952

7.  "Mismatch" in regional myocardial perfusion defects during exercise and pharmacologic vasodilation: a noninvasive marker of epicardial vasomotor dysfunction?

Authors:  Thomas H Schindler; Heinrich H Schelbert
Journal:  J Nucl Cardiol       Date:  2007 Nov-Dec       Impact factor: 5.952

8.  'Cold as ice', why do old coronary arteries pay the price?

Authors:  Shannon Lennon-Edwards; William B Farquhar
Journal:  J Physiol       Date:  2013-06-01       Impact factor: 5.182

9.  Coronary Exercise Hyperemia Is Impaired in Patients with Peripheral Arterial Disease.

Authors:  Amanda J Ross; Zhaohui Gao; Jonathan Carter Luck; Cheryl A Blaha; Aimee E Cauffman; Faisal Aziz; John F Radtka; David N Proctor; Urs A Leuenberger; Lawrence I Sinoway; Matthew D Muller
Journal:  Ann Vasc Surg       Date:  2016-08-27       Impact factor: 1.466

10.  Early Life Adversity with Height Stunting Is Associated with Cardiometabolic Risk in Adolescents Independent of Body Mass Index.

Authors:  Brie M Reid; Michelle M Harbin; Jessica L Arend; Aaron S Kelly; Donald R Dengel; Megan R Gunnar
Journal:  J Pediatr       Date:  2018-08-23       Impact factor: 4.406

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.